Hamilton Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.3M Sell
87,412
-17,071
-16% -$995K 1.03% 27
2025
Q4
$2.42M Sell
104,483
-95,300
-48% -$4.58M 0.46% 41
2025
Q3
$9.01M Buy
199,783
+121,956
+157% +$5.7M 1.88% 16
2025
Q2
$3.6M Buy
77,827
+2,825
+4% +$139K 0.81% 34
2025
Q1
$4.57M Buy
75,002
+3,550
+5% +$207K 1.1% 23
2024
Q4
$4.04M Sell
71,452
-124,446
-64% -$6.95M 0.98% 28
2024
Q3
$10.1M Buy
+195,898
New +$9.19M 2.48% 15
2024
Q2
Sell
-66,548
Closed -$3.61M 103
2024
Q1
$3.61M Buy
66,548
+34,284
+106% +$1.75M 1.13% 27
2023
Q4
$1.66M Buy
+32,264
New +$1.69M 0.52% 40
2023
Q2
Sell
-38,491
Closed -$2.67M 94
2023
Q1
$2.67M Sell
38,491
-671
-2% -$47.3K 0.94% 25
2022
Q4
$2.82M Buy
39,162
+19,312
+97% +$1.46M 1.15% 26
2022
Q3
$1.41M Buy
+19,850
New +$1.44M 0.6% 37
2021
Q1
Sell
-33,310
Closed -$2.07M 55
2020
Q4
$2.07M Sell
33,310
-471
-1% -$29K 1.06% 34
2020
Q3
$2.04M Buy
33,781
+419
+1% +$25.2K 1.14% 31
2020
Q2
$1.96M Sell
33,362
-46,580
-58% -$2.79M 1.17% 31
2020
Q1
$4.46M Buy
79,942
+1,016
+1% +$62.1K 3.33% 12
2019
Q4
$5.07M Buy
78,926
+1,339
+2% +$76.7K 3.43% 11
2019
Q3
$3.93M Buy
77,587
+33,297
+75% +$1.56M 2.8% 14
2019
Q2
$2.01M Buy
+44,290
New +$2.06M 1.47% 25

Other funds holding BMY

Hamilton Wealth's BMY Position: Q1 2026 in Review

Hamilton Wealth reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, selling an estimated $995K and leaving 87,412 shares worth $5.3M. The position accounts for 1.03% of the portfolio, ranked #27.

Hamilton Wealth first reported a position in BMY in Q2 2019 and has held it in 19 quarters since. The position peaked at $10.1M in Q3 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hamilton Wealth held 87,412 shares of Bristol-Myers Squibb worth $5.3M as of Q1 2026.
  • Hamilton Wealth sold 17,071 Bristol-Myers Squibb shares in Q1 2026, an estimated $995K.
  • Bristol-Myers Squibb made up 1.03% of Hamilton Wealth's portfolio in Q1 2026, its #27 holding.
  • Hamilton Wealth first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 19 quarters since.
  • Hamilton Wealth's Bristol-Myers Squibb position peaked at $10.1M in Q3 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.